Cleared Traditional

K931050 - CARDIO REP CK ISOENZYME KIT - 3310

K931050 is the FDA 510(k) clearance for CARDIO REP CK ISOENZYME KIT - 3310 by Helena Laboratories. It is a Class 2 Chemistry device (product code JHW) cleared through the Traditional 510(k) pathway after a 50-day FDA review.

K931050 · Helena Laboratories · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1993
Decision
50d
Days
Class 2
Risk

K931050 is an FDA 510(k) clearance for the CARDIO REP CK ISOENZYME KIT - 3310. Classified as U.v. Method, Cpk Isoenzymes (product code JHW), Class II - Special Controls.

Submitted by Helena Laboratories (Beaumont, US). The FDA issued a Cleared decision on April 20, 1993 after a review of 50 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1215 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Helena Laboratories devices

Submission Details

510(k) Number K931050 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 01, 1993
Decision Date April 20, 1993
Days to Decision 50 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
38d faster than avg
Panel avg: 88d · This submission: 50d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JHW U.v. Method, Cpk Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1215
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JHW U.v. Method, Cpk Isoenzymes

All 12
Devices cleared under the same product code (JHW) and FDA review panel - the closest regulatory comparables to K931050.
ELECSYS CK-MB
K961501 · Boehringer Mannheim Corp. · Jun 1996
LIFESIGN, CARE POINT, VITALSIGN, ACCUSIGN
K944325 · Princeton BioMeditech Corp. · Feb 1995
AXSYM CK-MB
K935924 · Abbott Laboratories · Jun 1994
DSL 1700
K822897 · Diagnostic Systems Laboratories, Inc. · Dec 1982
CARDIOZYME PLUS CK-MB ITEM #65045
K811573 · Harleco · Jun 1981
CARDIOZYME PLUS CK-MB ITEM #65045 (G)
K811575 · Harleco · Jun 1981